Vanguard Group’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.16M Buy
269,582
+188,482
+232% +$719K ﹤0.01% 3737
2025
Q3
$352K Buy
81,100
+46,019
+131% +$208K ﹤0.01% 4024
2025
Q2
$163K Buy
+35,081
New +$139K ﹤0.01% 4106

Other funds holding SBC

Vanguard Group's SBC Position: Q4 2025 in Review

Vanguard Group increased its SBC Medical Group (SBC) stake by 232% in Q4 2025, buying an estimated $719K and bringing the position to 269,582 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

Vanguard Group first reported a position in SBC in Q2 2025 and has held it in 3 quarters since. 42 funds tracked by Wall St. Rank hold SBC as of Q4 2025.

  • Vanguard Group held 269,582 shares of SBC Medical Group worth $1.16M as of Q4 2025.
  • Vanguard Group bought 188,482 SBC Medical Group shares in Q4 2025, an estimated $719K.
  • SBC Medical Group made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3737 holding.
  • Vanguard Group first reported a position in SBC Medical Group in Q2 2025 and has held it in 3 quarters since.
  • 42 funds tracked by Wall St. Rank held SBC Medical Group as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.